Hemodialysis Access Clinical Trials

2 recruiting

Hemodialysis Access Trials at a Glance

9 actively recruiting trials for hemodialysis access are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Shanghai, Charlotte, and Houston. Lead sponsors running hemodialysis access studies include RenJi Hospital, Mario Negri Institute for Pharmacological Research, and Merit Medical Systems, Inc..

Browse hemodialysis access trials by phase

Treatments under study

About Hemodialysis Access Clinical Trials

Looking for clinical trials for Hemodialysis Access? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hemodialysis Access trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hemodialysis Access clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

Chronic Kidney DiseasesArteriovenous FistulaVascular Access Complication+7 more
VenoStent600 enrolled28 locationsNCT06001827
Recruiting
Not Applicable

Pivotal Study of the Velocity™ pAVF System

Chronic Kidney DiseaseEnd Stage Renal Disease (ESRD)Hemodialysis Access+1 more
Venova Medical126 enrolled10 locationsNCT07153939
Recruiting
Not Applicable

Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care

Hemodialysis AccessArteriovenous FistulaArteriovenous Fistula Cannulation+2 more
Suzhou Municipal Hospital of Anhui Province100 enrolled1 locationNCT07372027
Recruiting

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

End Stage Renal DiseaseHemodialysis Access Failure
Merit Medical Systems, Inc.100 enrolled3 locationsNCT06422871
Recruiting

Acoustic Analysis of VA Sounds

End Stage Renal DiseaseHemodialysis Access Failure
Mario Negri Institute for Pharmacological Research44 enrolled1 locationNCT05612022
Recruiting

DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis

Arteriovenous FistulaHemodialysis Access FailureAngioplasty, Balloon
RenJi Hospital180 enrolled3 locationsNCT06527963
Recruiting

Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

Hemodialysis Access Failure
RenJi Hospital180 enrolled3 locationsNCT06493292
Recruiting

Effectiveness and Health Economics of Endoluminal Treatment of Arteriovenous Graft Fistula.

Hemodialysis Access Failure
RenJi Hospital240 enrolled1 locationNCT06470646
Recruiting

Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

Hemodialysis Access Failure
RenJi Hospital480 enrolled1 locationNCT06454396